GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (FRA:J90) » Definitions » Forward Dividend Yield %

NurExone Biologic (FRA:J90) Forward Dividend Yield % : 0.00% (As of Mar. 30, 2025)


View and export this data going back to 2022. Start your Free Trial

What is NurExone Biologic Forward Dividend Yield %?

As of today (2025-03-30), the Forward Annual Dividend Yield of NurExone Biologic is 0.00%.

As of today (2025-03-30), the Trailing Annual Dividend Yield of NurExone Biologic is 0.00%.

FRA:J90's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.46
* Ranked among companies with meaningful Forward Dividend Yield % only.

NurExone Biologic's Dividends per Share for the three months ended in Sep. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of NurExone Biologic's Forward Dividend Yield %

For the Biotechnology subindustry, NurExone Biologic's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NurExone Biologic's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NurExone Biologic's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where NurExone Biologic's Forward Dividend Yield % falls into.


;
;

NurExone Biologic Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


NurExone Biologic  (FRA:J90) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


NurExone Biologic Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


NurExone Biologic Business Description

Traded in Other Exchanges
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.

NurExone Biologic Headlines

No Headlines